Cargando…
Systematic Review With Network Meta-Analysis: Adjuvant Chemotherapy for Resected Colorectal Liver Metastases
There are 5 major adjuvant chemotherapies (ACTs) for hepatic metastases for colorectal cancer; however, the optimal treatment regimen remains inconclusive. Here, we aim to compare these therapies in terms of patient survival rate, intrahepatic recurrence rate, and adverse events. Different databases...
Autores principales: | Zhu, Gui-Qi, You, Jie, Shi, Ke-Qing, He, Sun-Yue, Wang, Li-Ren, Chen, Yong-Ping, Braddock, Martin, Zheng, Ming-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602852/ https://www.ncbi.nlm.nih.gov/pubmed/25569666 http://dx.doi.org/10.1097/MD.0000000000000379 |
Ejemplares similares
-
Nonalcoholic Fatty Liver Disease: A Negative Risk Factor for Colorectal Cancer Prognosis
por: You, Jie, et al.
Publicado: (2015) -
Increased Levels of Systolic Blood Pressure Within the Normal Range Are Associated With Significantly Elevated Risks of Nonalcoholic Fatty Liver Disease
por: Wu, Sheng-Jie, et al.
Publicado: (2015) -
Optimal timing for the resection of pulmonary metastases in patients with colorectal cancer
por: Yamada, Kazunosuke, et al.
Publicado: (2020) -
Network Meta-Analysis of Randomized Controlled Trials: Efficacy and Safety of UDCA-Based Therapies in Primary Biliary Cirrhosis
por: Zhu, Gui-Qi, et al.
Publicado: (2015) -
Association Between Sex-Specific Serum Uric Acid and Non-Alcoholic Fatty Liver Disease in Chinese Adults: A Large Population-Based Study
por: Wu, Sheng-Jie, et al.
Publicado: (2015)